Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

IND to test androxal in men with type 2 diabetes and hypogonadism now effective

Feb. 4, 2010

Kalbitor now available on U.S. market

Feb. 3, 2010

Zelos Therapeutics initiates dosing in phase I nasal spray teriparatide trial

Feb. 2, 2010

Pfizer claims CRF1 receptor antagonists for treatment of female sexual disorders

Feb. 2, 2010

European Commission approves Merck's MAA for fertility treatment Elonva

Feb. 1, 2010

Diamyd to file for market approval of Diamyd diabetes vaccine in 2011

Feb. 1, 2010

Amarin presents update on MARINE and ANCHOR phase III clinical trials of AMR-101

Feb. 1, 2010

Genfit reports results from completed phase II trial of GFT-505

Feb. 1, 2010

Warner Chilcott received complete response letter for low dose oral contraceptive

Jan. 29, 2010

Repros receives guidance from FDA on Androxal in secondary hypogonadism

Jan. 29, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...